Welcome : Guest

BLOOD BANKING AND BLOOD PRODUCTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Group/Types: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 235 companies including many key and niche players such as -

AABB
America’s Blood Centers
American Red Cross
Canadian Blood Services
Japan Red Cross Society

Click here to request a full list of companies covered in the report...

Code: MCP-1028
Price: $4950
Companies: 235
Pages: 553
Date: October 2015
Market Data Tables: 160
 



TABLE OF CONTENTS


  BLOOD BANKING AND BLOOD PRODUCTS (Complete Report) Pages : 553   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Prelude.....II-1
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts.....II-1
1$100
   Safety and Availability: The Core Issues.....II-2 1$100
   Table 1: Prevalence of Major Transfusion-transmitted Infections by Economic Group (H2 2014): Percentage of HIV, HBV and HCV in High Income, Middle-income and Low Income Countries (includes corresponding Graph/Chart).....II-31$350
   Current and Future Analysis.....II-4
Analysis of World Blood Banking & Blood Products by Value Sales.....II-4
Analysis by Geographic Region.....II-4
Analysis by Product Group/Type.....II-4
Plasma and Plasma Derivatives Continue to Dominate Blood Components Market.....II-4
1$100
   Table 2: Global Plasma Derivatives Market by Product (2015E & 2017P): Percentage Breakdown of Consumption Value for Albumin, Alpha-1, FVIII, IVIg, and Others (includes corresponding Graph/Chart).....II-51$350
   Equipment, Blood Tests & Other Consumables to Display Steady Growth.....II-61$100
   World Blood Components and Plasma Market Analysis.....II-7 1$100
   Table 3: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-81$350
   Table 4: World 7-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2014, 2015 & 2020 (includes corresponding Graph/Chart).....II-91$350
   Red Blood Cells – A Key Blood Component.....II-10
Table 5: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/ Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-10
1$350
   Table 6: World 7-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2014, 2015 & 2020 (includes corresponding Graph/Chart).....II-111$350
   Blood Plasma Demand Exceeds Supply: Self-Sufficiency is the New Mantra.....II-12
Manufacturers Step Up Production Capacity to Meet Growing Demand for Plasma Derivative
  Products.....II-12
Platelet Rich Plasma Therapy Market Scales New Heights.....II-12
1$100
   Increasing Awareness of PID and CIPD Disorders to Drive IVIg Market.....II-131$100
   Indications Addressed by Major Global IVIg Manufacturers.....II-14
Table 7: Comparative Costs between Plasma Protein Therapies and Artificially Synthesized Pharmaceuticals (includes corresponding Graph/Chart).....II-14
1$350
   Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg
  Therapy.....II-15
2$200
   Table 8: Worldwide Home Healthcare Services Market by Type of Service (2015E & 2020P): Percentage Breakdown of Service Revenues for Infusion Therapy Services, Rehabilitation Services, Respiratory Therapy Services, Telemetry, and Unskilled Homecare (includes corresponding Graph/Chart).....II-17
Unsuccessful Clinical Trials for Alzheimer’s a major Setback for IVIg Market.....II-17
1$350
   Huge Under-Diagnosed Pool of AAT Patients Highlights High Potential for Alpha-1
  Protein.....II-18
Rising Incidence of Cancer Drives Demand for Apheresis Systems.....II-18
1$100
   PrIME: An Innovative High-Yield Process to Address Supply Dearth.....II-19
Present State of Plasma Fractionating Industry.....II-19
1$100
   Plasma Fractionation Industry Concentrated in Developed Countries.....II-20
PrIME Tackles the Issue of Currently Unprocessable Plasma.....II-20
Industry Grappling with Blood Safety & Availability Issues.....II-20
1$100
   New Infections – A Continuous Threat.....II-21
Synthetic Substitutes to Bridge Demand-Supply Gap in Blood.....II-21
1$100
   Autologous Transfusion Gearing up for High Growth.....II-22
Out-of-Hospital Transfusions: An Emerging Phenomenon.....II-22
1$100
   Automation Tapping into Blood Market.....II-23
Automated in Pre-Transfusion Diagnostics.....II-23
Penetration of Automated Equipment in the Plasma Market.....II-23
The Red Blood Cell Collection Opportunity.....II-23
1$100
   Robots in Blood Banking.....II-24
Blood Banks Switching from Manual to Automated Cooler Validation.....II-24
Automated Blood Processing Systems in Open Heart Surgeries.....II-24
1$100
   Automated Systems in Cancer.....II-25
Pooling: Economical HIV Testing.....II-25
Ballooning Global Geriatric Populace to Drive Demand for Blood Products`.....II-25
1$100
   Table 9: Elderly Population (65+ Years) as a Percentage of the Total Population: 2014 & 2025 (includes corresponding Graph/Chart).....II-26

Table 10: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart).....II-26
1$350
   Improving Healthcare Expenditure to Foster Growth of Blood Banking Sector.....II-27 1$100
   Table 11: Global Intravenous Immunoglobulin Consumption in Kilograms per Million Residents for Select Countries (includes corresponding Graph/Chart).....II-281$350
   Table 12: Per-Capita Healthcare Expenditure in US$ for Select Regions (2014) (includes corresponding Graph/Chart).....II-291$350
   Leaders in Global Blood Plasma Ramp Up Market Share.....II-30
Table 13: Global Plasma Fractionation Capacity by Leading Producers (2016 & 2020): Percentage Breakdown of Production Capacity for Baxter, Biotest, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....II-30
1$350
   IVIg – A Highly Consolidated Market.....II-31
Table 14: Global Market for Immunoglobulin (IVIg and SCIg) by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....II-31
1$350
   Table 15: Global IVIg Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....II-32
Select IVIg Products Offered by Global Leading Players.....II-32
Table 16: Global Subcutaneous Immunoglobulin Market by Leading Player (2014): Percentage Market Share Breakdown of Revenue for Baxter, CSL, and Grifols (includes corresponding Graph/Chart).....II-32
1$350
   Big Three Corner Majority of Blood Collection Systems Market.....II-33
Table 17: Global Whole Blood Collection Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, MacoPharma, Terumo, WEGO, and Others (includes corresponding Graph/Chart).....II-33
1$350
   Table 18: Global Apheresis Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart).....II-34
Key Statistics.....II-34
Table 19: Global Human Albumin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Octapharma, and Others (includes corresponding Graph/Chart).....II-34

Table 20: Global Plasma-Derived Factor VIII Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, Biotest, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....II-34
1$350
   Table 21: Global Alpha-1 Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart).....II-35

Table 22: Global In-Vitro Diagnostics Instruments, Reagents & Supplies Market by Leading Players (2015E): Percentage Breakdown of Value Sales for Abbott, bioMérieux, Danaher, Johnson & Johnson, Roche, Siemens, and Others (includes corresponding Graph/Chart).....II-35

Table 23: Global Molecular Diagnostics Instruments, Reagents & Supplies Market by Leading Players (2015E): Percentage Breakdown of Value Sales for Abbott, Becton Dickinson, Gen-Probe/Hologic, Novartis, Qiagen, Roche, and Others (includes corresponding Graph/Chart).....II-35
1$350
   Blood Banking and Blood Products Industry.....II-36
Blood Components and Plasma Products.....II-36
Equipment, Blood Tests and Consumables.....II-36
Automated Analyzers for Blood Analysis.....II-36
Blood Tests.....II-36
1$100
   Consumables.....II-37
Blood Collection Equipment.....II-37
Blood Collection Monitors.....II-37
Blood Donor Couches.....II-37
Blood Processing Equipment.....II-37
Blood Bank Centrifuges.....II-37
Plasma Thawing.....II-37
1$100
   Blood Cell Separators.....II-38
Blood Storage Equipment.....II-38
Blood Bags.....II-38
Platelet Agitators.....II-38
Blood Bank Refrigerators.....II-38
Blood – A Primer.....II-38
Ionic Structure.....II-38
1$100
   Blood Components and their Applications.....II-391$100
   Blood Constituents.....II-40
Plasma.....II-40
Red Blood Cells (RBC).....II-40
1$100
   Blood Count.....II-41
Platelets.....II-41
White Blood Cells (WBC).....II-41
1$100
   Derivative Products of Blood or Plasma Fractions.....II-42
Albumin Fractions.....II-42
Immunoglobulins.....II-42
Hyper-Immune Immunoglobulin.....II-42
1$100
   Factor VIII.....II-43
Factor IX and Factor IX Complex.....II-43
Fibrin/Thrombin.....II-43
Consumption of Blood Based on Type of Surgery/Accident (In Units).....II-43
1$100
   Table 24: Worldwide Market for Plasma Derivative Products by Product Type (2014): Percentage Breakdown of Revenue Sales for A1PI, Albumin, Coagulation Factor, Hyperimmunes, IVIG, Plasma Derived Factor VIII, Prothrombin Complex Concentrate, and Others (includes corresponding Graph/Chart).....II-44
Recombinant Products.....II-44
1$350
   Development Pipeline of Select rFVIII Products Developed for Hemophilia
  Therapy.....II-45
Blood Plasma Sourcing.....II-45
Table 25: Global Plasma Derivatives Market: Percentage Breakdown of Costs Associated with Production (includes corresponding Graph/Chart).....II-45
1$350
   Plasma Protein and Fractionation.....II-46
Plasma Fractionation: Origins and Development.....II-46
1$100
   Table 26: Plasma Fractionation Processes: Comparison of Cohn IVIG and PrIME IVIG Based on Specific Characteristics.....II-47
The Need.....II-47
Fresh Frozen Plasma.....II-47
1$350
   Other Plasma Fractions.....II-48
IVIG.....II-48
Factor VIII.....II-48
Albumin.....II-48
Therapeutic Uses of Plasma Products.....II-48
Albumin Products.....II-48
1$100
   Immunoglobulins.....II-49
Intravenous Immunoglobulin (IVIg).....II-49
Normal Immunoglobulin (IMIg).....II-49
CMV Immunoglobulin.....II-49
Hepatitis B Immunoglobulin.....II-49
Rh (D) Immunoglobulin.....II-49
Tetanus Immunoglobulin IM.....II-49
1$100
   Zoster Immunoglobulin.....II-50
Plasma Derived Coagulant Products.....II-50
Biostate®.....II-50
Ceprotin®.....II-50
Factor VII Concentrate.....II-50
Factor XI Concentrates.....II-50
Feiba VH® Inhibitor Treatment.....II-50
Fibrogammin P®.....II-50
Monofix®-VF.....II-50
1$100
   ProthrombinexTM-HT.....II-51
Thrombotrol®-VF.....II-51
1$100
   Banking the Natural Blood Resources.....II-52
Blood Banks.....II-52
Blood Banking.....II-52
Blood Transfusion.....II-52
Role of Blood Banks.....II-52
Blood Donor: The Epicenter of the Process.....II-52
1$100
   Eligibility Criteria for the Donor.....II-53
The Basics of Blood Donation – Myths & Facts.....II-53
1$100
   Table 27: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/ Agency (includes corresponding Graph/Chart).....II-541$350
   Table 28: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (includes corresponding Graph/Chart).....II-55
Collection Methods.....II-55
Blood Donation: The Process.....II-55
Types of Blood Donation.....II-55
Directed Blood Donations.....II-55
1$350
   Autologous Blood Donation.....II-56
Alternative Usage of Patient’s Own Blood.....II-56
General Blood Donation.....II-56
Hemodilution.....II-56
Wound Drainage.....II-56
Cell Saver.....II-56
1$100
   The Method.....II-57
Blood Salvaging.....II-57
Blood Collection Centers.....II-57
Blood Collection Management System.....II-57
A Historical Retrospective.....II-57
Blood Collection Centers.....II-57
1$100
   Types of Blood Collection Centers.....II-58
Cord Blood Banks.....II-58
Profit Collection Centers.....II-58
Military Blood Banks.....II-58
Hospital Blood Banks.....II-58
1$100
   Community Blood Banks.....II-59
Non-Profit Collection Centers.....II-59
Blood Processing.....II-59
1$100
   Blood Typing.....II-60
Rh Blood Group System.....II-60
ABO Blood Group System.....II-60
1$100
   Blood Types and their Compatibility.....II-61
Table 29: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart).....II-61
Blood Test.....II-61
1$350
   Blood Culture.....II-62
The Costs.....II-62
History of Blood Banking.....II-62
3$300
   Blood Transfusion: A Backdrop.....II-65
Massive Transfusion.....II-65
Complications and Risks Due to Transfusion.....II-65
1$100
   Circulatory Overload.....II-66
Graft Versus Host Disease (GVHD).....II-66
Hemolytic Transfusion Reactions.....II-66
Iron Overload.....II-66
Bacterial Contamination.....II-66
Thrombophlebitis.....II-66
Allergic Reactions.....II-66
1$100
   Air Embolism.....II-67
Hyperkalaemia.....II-67
Changing Role of Blood Banking Technology.....II-67
1$100
   Cross Matching.....II-68
Blood Donor/Recipient Screening.....II-68
Blood Typing.....II-68
Leukoreduction.....II-68
1$100
   Leukocyte Reduction Specification Standards/Filters.....II-69
Coombs Test.....II-69
1$100
   Bloodless Surgery.....II-70
Therapeutic Apheresis.....II-70
Plasmapheresis.....II-70
Plateletpheresis.....II-70
1$100
   Leukapheresis.....II-71
Volume Expanders.....II-71
Colloids.....II-71
Albumin.....II-71
Dextrans.....II-71
Hydroxyethyl Starch.....II-71
1$100
   Crystalloids.....II-72
Blood Growth Factor Therapies – Newer Alternatives to Transfusion.....II-72
1$100
   OneBlood to Merge with The Blood Alliance.....II-73
Cerus Corporation Inks Purchase Agreement with Karolinska University Hospital.....II-73
Cerus Corporation Signs Purchase Agreement with Blood Bank of Delmarva.....II-73
Canadian Blood Services Closes 3 Permanent Clinics, Terminates Bloodmobile
  Program.....II-73
Roche Releases Elecsys HTLV-I/II Immunoassay.....II-73
Roche Receives USFDA Approval for cobas TaqScreen MPX Test v2.0 for HIV, HCV, and
  HBV Tests.....II-73
China Biologic Products Purchases Additional Stake in Guizhou Taibang Biological
  Products.....II-73
1$100
   Community Blood Center Merges with New York Blood Center.....II-74
Cerus Corp. Partners with Kawasumi Laboratories for Developing Intercept Platelets
  Kits.....II-74
Vascular Solutions Collaborates with US AMMDA to Develop Plasma Products for Treating
  Hemorrhage.....II-74
The San Diego Blood Bank Collaborates with Clinical and Translational Research
  Institute.....II-74
Affinity Biologicals Unveils Factor VIII Deficient, Factor IX Deficient
  Plasmas.....II-74
AABB Collaborates with AATM for Promoting Blood and Cellular Therapies Standards in
  Asia.....II-74
1$100
   bioCSL Partners with Immucor for Distributing Transfusion Technology in Australia and
  New Zealand.....II-75
PrIME Biologics Opens Plasma Fractionation Plant in Singapore.....II-75
Terumo BCT Acquires Medservice.....II-75
Grifols Acquires Transfusion Diagnostics Unit of Novartis.....II-75
Lab21 Divests Blood Bank Screening, Molecular Assets to Trinity Biotech.....II-75
New York Blood Center Acquires Coral Blood Services.....II-75
Entegrion Inks Licensing Agreement with Kedrion Melville for Developing
  Resusix.....II-75
Davao del Norte Opens New Blood Banking Facility.....II-75
1$100
   Leading Blood Banks.....II-76
AABB (USA).....II-76
America’s Blood Centers (USA).....II-76
1$100
   American Red Cross (USA).....II-77
Canadian Blood Services (Canada).....II-77
1$100
   Japan Red Cross Society (Japan).....II-78
New York Blood Center (USA).....II-78
Sanquin Blood Supply Foundation (The Netherlands).....II-78
1$100
   Leading Players in Blood Bank Technology and Supplies.....II-79
Abbott Diagnostics, Inc. (USA).....II-79
Beckman Coulter, Inc. (USA).....II-79
1$100
   Becton, Dickinson and Company (USA).....II-801$100
   bioMérieux SA (France).....II-81
Bio-Rad Laboratories, Inc. (USA).....II-81
1$100
   Cerus Corporation (USA).....II-82
CSL Behring LLC (USA).....II-82
1$100
   Fresenius Kabi AG (Germany).....II-83
Fenwal Inc. (USA).....II-83
1$100
   Gen-Probe, Inc. (USA).....II-84
Haemonetics Corporation (USA).....II-84
1$100
   Immucor Inc. (USA).....II-851$100
   Kawasumi Laboratories, Inc. (Japan).....II-86
MacoPharma SA (France).....II-86
Ortho-Clinical Diagnostics, Inc. (USA).....II-86
1$100
   Terumo BCT Inc. (USA).....II-87
Leading Players in Plasma Fractionation.....II-87
Baxter International Inc. (USA).....II-87
1$100
   Beijing Tiantan Biological Products Co., Ltd (China).....II-88
Bharat Serums and Vaccines Ltd (India).....II-88
Bio Products Laboratory Ltd (UK).....II-88
1$100
   Biotest AG (Germany).....II-89
China Biologic Products, Inc. (China).....II-89
Grifols S.A. (Spain).....II-89
2$200
   Huanlan Biological Engineering Inc. (China).....II-91
Kedrion S.p.A. (Italy).....II-91
LFB Group (France).....II-91
1$100
   Octapharma AG (Switzerland).....II-92
OMRIX Biopharmaceuticals Ltd (Israel).....II-92
1$100
   Shanghai RAAS Blood Products Co., Ltd. (China).....II-93
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China).....II-93
1$100
   Table 30: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-941$350
   Table 31: World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-951$350
   Table 32: World 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-961$350
   Blood Banking and Blood Products Market by Product Group/Type.....II-97
Table 33: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-97
1$350
   Table 34: World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-981$350
   Table 35: World 14-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-991$350
   Table 36: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-1001$350
   Table 37: World Historic Review for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-1011$350
   Table 38: World 14-Year Perspective for Blood Components and Plasma Products by Product Type - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-1021$350
   Table 39: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-1031$350
   Table 40: World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-1041$350
   Table 41: World 14-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-1051$350
   Table 42: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-1061$350
   Table 43: World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-1071$350
   Table 44: World 14-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-1081$350
   Table 45: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-1091$350
   Table 46: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-1101$350
   Table 47: World 14-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-1111$350
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
Demand for Blood Transfusion Continues to Wane.....III-1
1$75
   Table 48: US Blood and Organ Banks by Leading Players (2014): Percentage Share Breakdown of Revenues for American Red Cross, Baxter International Inc., Blood Systems, Musculoskeletal Transplant Foundation, New York Blood Center, and Others (includes corresponding Graph/Chart).....III-21$200
   Table 49: US Blood Banking Market by Leading Suppliers (2015): Percentage Breakdown of Unit Volumes for American Red Cross, Blood Centers of America, and Others (includes corresponding Graph/Chart).....III-3

Table 50: American Red Cross Dominates US Blood Platelet Production (2014): Percentage Share Breakdown of Production Volume for American Red Cross, and Others (includes corresponding Graph/Chart).....III-3
Aging Baby-Boomer Demography: A Key Market Driver.....III-3
1$200
   Table 51: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-4
Favorable Reimbursement and High Usage Make US the Largest Consumer of
  Immunoglobulins Worldwide.....III-4
Recession Impacts Blood Bank Reserves.....III-4
1$200
   US Blood Collection & Supply Profile.....III-5
Blood Group Distribution.....III-5
1$75
   Table 52: US Market for Blood Banking and Blood Products: Percentage Breakup of Blood Group by Rh Factor (includes corresponding Graph/Chart).....III-6

Table 53: Percentage Breakup of Rh Blood Types in the US by Racial Group (includes corresponding Graph/Chart).....III-6
US Plasma Industry Remains Highly Concentrated.....III-6
1$200
   Table 54: US Plasma Derivatives Market by Leading Suppliers (2015): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart).....III-7

Table 55: US Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, CSL Ltd., Grifols, and Others (includes corresponding Graph/Chart).....III-7
1$200
   Table 56: US Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales for Baxter, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....III-8

Table 57: US Market for Immunoglobulin by Leading Players (2014): Percentage Breakdown of Value Sales for Gammagard Liquid/Kiovig, Flebogamma/Gamunex, Privigen/Carimune NF, Octagam and Others (includes corresponding Graph/Chart).....III-8
1$200
   Table 58: US Market for IVIg Products by Indication (2014 & 2020P): Percentage Breakdown of Volume Sales for CIDP, CLL, ITP, MMN, PID, and Other Neurological Diseases (includes corresponding Graph/Chart).....III-9

Table 59: US Specific Immunoglobulin Market by Product Type (2014): Percentage Breakdown of Value Sales for Anti-D, Anti-HB, Anti-T, and Rabies Immunoglobulin (includes corresponding Graph/Chart).....III-9
1$200
   Table 60: US Specific Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Biotest, Cangene, CSL, Grifols, Kedrion, Sanofi (includes corresponding Graph/Chart).....III-10
Changing Supply Dynamics Alters Economics of Plasma Production.....III-10
1$200
   Table 61: Average Price per Gram of IVIg for Europe and US Markets (includes corresponding Graph/Chart).....III-111$200
   Regulations Control Plasma Collection Industry.....III-12
Key Statistics.....III-12
Table 62: US Blood Bag (With Filters) Market (2014): Percentage Share Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart).....III-12

Table 63: US Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart).....III-12
1$200
   Table 64: US Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/ Fenwal, Haemonetics, and Terumo (includes corresponding Graph/Chart).....III-13
Strategic Corporate Activity.....III-13
1$200
   Select Key Players.....III-149$675
   B. Market Analytics.....III-23
US Blood Components and Plasma Market Analyzed by Value Sales.....III-23
Table 65: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-23
1$200
   Table 66: US Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-241$200
   Table 67: US 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-251$200
   US Blood Components and Plasma Market Analyzed by Consumption in Units.....III-26
Table 68: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Blood Components- Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-26
1$200
   Table 69: US Historic Review for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-271$200
   Table 70: US 14-Year Perspective for Blood Components and Plasma by Blood Components - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Current and Future Analysis.....III-29
Bleeding Disorders – A Major Threat.....III-29
'CSA-Z902-04' – A Comprehensive Voluntary Blood Safety Standard.....III-29
1$75
   Strategic Corporate Developments.....III-30
Canadian Blood Services – The Major Blood Bank.....III-30
1$75
   B. Market Analytics.....III-31
Table 71: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-31
1$200
   Table 72: Canadian Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-321$200
   Table 73: Canadian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Current and Future Analysis.....III-34
Japan Witnesses Surge in Imported Blood Products.....III-34
Growing Market for Fresh Frozen Plasma.....III-34
Growing Use of Imported Albumin Based Blood Products.....III-34
1$75
   The Goal of Self-Sufficiency.....III-35
Graying Population to Drive Market Growth.....III-35
1$75
   Table 74: Japanese Elderly (65+ Years) Population for the Period 2000-2020 (includes corresponding Graph/Chart).....III-36
Corporate Development.....III-36
1$200
   Select Players.....III-371$75
   B. Market Analytics.....III-38
Table 75: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-38
1$200
   Table 76: Japanese Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-391$200
   Table 77: Japanese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-401$200
   A. Market Analysis.....III-41
Current and Future Analysis.....III-41
Market Trends and Issues.....III-41
Legislations on Payment for Donation Restrict Donors.....III-41
Government’s Check on Healthcare Costs Pressurizes BCT Manufacturers.....III-41
Purchasing System Witnesses Modifications.....III-41
1$75
   Aging Population to Drive Demand for IVIg Products.....III-42
Table 78: Aging Population in Europe by Geographic Region (2015E & 2020): Percentage of Elderly Individuals of Age 60 Years and Above Compared to Overall Population for Eastern Europe, Northern Europe, Southern Europe, and Western Europe (includes corresponding Graph/Chart).....III-42
1$200
   Table 79: European Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales by Plasma Fractionators for Baxter Healthcare, Biotest, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....III-43
Overview of Blood Banking Market.....III-43
1$200
   Table 80: European Blood Bag Market (2014E): Percentage Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo and Others (includes corresponding Graph/Chart).....III-44

Table 81: European Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo, and Others (includes corresponding Graph/Chart).....III-44

Table 82: European Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart).....III-44
1$200
   B. Market Analytics.....III-45
Table 83: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-45
1$200
   Table 84: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-461$200
   Table 85: European 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-471$200
   Table 86: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-481$200
   Table 87: European Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-491$200
   Table 88: European 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Current and Future Analysis.....III-51
Key Players.....III-51
2$150
   B. Market Analytics.....III-53
Table 89: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-53
1$200
   Table 90: French Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-541$200
   Table 91: French 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-551$200
   A. Market Analysis.....III-56
Current and Future Analysis.....III-56
Select Players.....III-56
2$150
   B. Market Analytics.....III-58
Table 92: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-58
1$200
   Table 93: German Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-591$200
   Table 94: German 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-601$200
   A. Market Analysis.....III-61
Current and Future Analysis.....III-61
Kedrion S.P.A. – A Leading Italian Player for Plasma Fractionation.....III-61
1$75
   B. Market Analytics.....III-62
Table 95: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-62
1$200
   Table 96: Italian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-631$200
   Table 97: Italian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-641$200
   A. Market Analysis.....III-65
Current and Future Analysis.....III-65
Bio Products Laboratory Ltd – A Leading UK Player for Plasma Fractionation.....III-65
1$75
   B. Market Analytics.....III-66
Table 98: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-66
1$200
   Table 99: UK Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-671$200
   Table 100: UK 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-681$200
   A. Market Analysis.....III-69
Current and Future Analysis.....III-69
Grifols, S.A – A Leading Spanish Player for Plasma Fractionation.....III-69
2$150
   B. Market Analytics.....III-71
Table 101: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-71
1$200
   Table 102: Spanish Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-721$200
   Table 103: Spanish 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-731$200
   Market Analysis.....III-74
Table 104: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020(includes corresponding Graph/Chart).....III-74
1$200
   Table 105: Russian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-751$200
   Table 106: Russian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-761$200
   A. Market Analysis.....III-77
Current and Future Analysis.....III-77
Denmark – High Participation and Consumption of Blood.....III-77
Strategic Corporate Developments.....III-77
1$75
   Select Players.....III-781$75
   B. Market Analytics.....III-79
Table 107: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-79
1$200
   Table 108: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-801$200
   Table 109: Rest of Europe 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-811$200
   A. Market Analysis.....III-82
Current and Future Analysis.....III-82
Table 110: Asia-Pacific Whole Blood Collection Market (2014E): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Weigao, and Others (includes corresponding Graph/Chart).....III-82

Table 111: Asia-Pacific Automated Blood Collection Market (2014E): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart).....III-82
1$200
   ASEAN – Striding Towards Standardization of Blood Supply.....III-83
B. Market Analytics.....III-83
Table 112: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-83
1$200
   Table 113: Asia-Pacific Historic Review for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-841$200
   Table 114: Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for China, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-851$200
   Table 115: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-861$200
   Table 116: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-871$200
   Table 117: Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-881$200
   A. Market Analysis.....III-89
A Key Market.....III-89
Government Wakes Up to Realities.....III-89
1$75
   Table 118: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart).....III-90

Table 119: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female (includes corresponding Graph/Chart).....III-90

Table 120: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes corresponding Graph/Chart).....III-90
1$200
   Overview of Chinese Blood Plasma Market.....III-91
Table 121: Chinese Blood Products Demand by Type of Product (2014): Percentage Breakdown of Lot Release Volumes for Human IVIG, Human Albumin, Human Rabies Ig, Human Tetanus Ig, and Others (includes corresponding Graph/Chart).....III-91
1$200
   Availability of Plasma Proteins in the US and China (2015): A Comparison.....III-92 1$75
   Table 122: Chinese Plasma Based Products Market by Product Type (2015 & 2020P): Percentage Breakdown of Value Sales for Human Albumin, Human IVIg, and Others (includes corresponding Graph/Chart).....III-931$200
   Government Exercises Strict Control Over Production, Supply and Import of Plasma-
  based Products.....III-94
Gap in Domestic Demand and Supply of Plasma Products Persists Despite Increasing
  Output.....III-94
1$75
   Table 123: Plasma Supply, Demand, and Deficit in Chinese Market: 2008-2014 (includes corresponding Graph/Chart).....III-951$200
   Table 124: Rising Number of Plasma Collection Stations and Volume of Plasma Collection in China: 2018-2014 (includes corresponding Graph/Chart).....III-96
Comparison of Average Yields for Select Plasma Based Products in China and
  International Markets.....III-96
Deregulation and Supply Crunch to Drive Up Retail Prices of Plasma-based
  Products.....III-96
1$200
   Expanding Medical Indications Holds Key to Boosting Market Growth.....III-97
Comparison of USFDA and CFDA Approved Indications for Human Albumin
  Therapeutic Products.....III-97
1$75
   Comparison of USFDA and CFDA Approved Indications for Human IVIG Therapeutic
  Products.....III-98
Competitive Landscape.....III-98
Table 125: Chinese Plasma Collection Stations Market by Leading Players (2014): Percentage Breakdown of Stations Owned by China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-98
1$200
   Blood Plasma Product Portfolio of Major Domestic Players.....III-99 1$75
   Table 126: Chinese Plasma Collection Market by Leading Players (2014): Percentage Volume Breakdown of Plasma Collection for Anhui Tonglu, CBPO, Chengdu Rongsheng, Hualan Biological, Shanxi Kangbao, Sichuan Shuyang, and Others (includes corresponding Graph/Chart).....III-100
Albumin Market in China Gains Favor of both Global and Local Players.....III-100
1$200
   Table 127: Chinese Human Albumin Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, China Biologic (CBPO), CNBG Shanghai Institute, CSL Behring, Grifols International, Octapharma, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-101
Key Statistics.....III-101
Table 128: Chinese IVIG (Intravenous Immunoglobulin) Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-101
1$200
   Table 129: Chinese Coagulation Factor VIII Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), Greencross China, Hualan Biological, and Shanghai RAAS (includes corresponding Graph/Chart).....III-102

Table 130: Chinese Hepatitis B Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Hunan Nanyue, Shenzhen Weiwu, Sichuan Yuanda Shuyang, and Others (includes corresponding Graph/Chart).....III-102
1$200
   Table 131: Chinese Rabies Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Guangdong Shuanglin Bio-Pharmacy, Hualan Biological, Hunan Nanyue, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart).....III-103

Table 132: Chinese Tetanus Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological , Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart).....III-103
1$200
   Table 133: Chinese Human PCC (Prothrombin Complex Concentrate) Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, and Others (includes corresponding Graph/Chart).....III-104

Table 134: Chinese Human Ig Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, and Sichuan Yuanda Shuyang Pharmaceutical (includes corresponding Graph/Chart).....III-104
1$200
   Table 135: Chinese Human Fibrinogen Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, Jiangxi Boya Bio-Pharmaceutical, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-105

Table 136: Chinese Plasma Collection Market by Leading Players (2014): Percentage Breakdown of Plasma Collection Volume for Anhui Tonglu, Chengdu Rongsheng Pharmaceutical, China Biologic (CBPO), Hualan Biological, Shanxi Kangbao Biological, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart).....III-105
1$200
   Table 137: Chinese Plasma Market by Leading Players (2014): Percentage Breakdown of Plasma Output Volume for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-106

Table 138: Leading Companies in the Chinese Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius, Shanghai Kindly Enterprise Development Group, Terumo, WEGO and Others (includes corresponding Graph/Chart).....III-106
1$200
   Strategic Corpoate Development.....III-107
Select Key Players.....III-107
2$150
   B. Market Analytics.....III-109
Table 139: Chinese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-109
1$200
   Table 140: Chinese Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1101$200
   Table 141: Chinese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1111$200
   A. Market Analysis.....III-112
Current and Future Analysis.....III-112
Overview of Select Regional Markets.....III-112
Australia.....III-112
National Blood Supply: An Overview.....III-112
Role of National Blood Authority.....III-112
Maintenance Expenditure on the Rise.....III-112
1$75
   India.....III-113
Demand for Blood Banking Equipment Market on the Rise.....III-113
1$75
   Recent Trends in the Market.....III-114
Indian Blood Banking Market Witnesses Major Transformations.....III-114
Market Growth – Influencing Factors.....III-114
1$75
   Increased Awareness Drives Voluntary Blood Donations in India.....III-115
Competitive Scenario.....III-115
1$75
   Indonesia.....III-116
Strategic Corporate Developments.....III-116
1$75
   Bharat Serums and Vaccines Ltd. – A Leading Indian Player for Plasma
  Fractionation.....III-117
1$75
   B. Market Analytics.....III-118
Table 142: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-118
1$200
   Table 143: Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1191$200
   Table 144: Rest of Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1201$200
   A. Market Analysis.....III-121
Current and Future Analysis.....III-121
Table 145: Leading Companies in the Latin American Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius/Fenwal, Grifols, JP, Terumo and Others (includes corresponding Graph/Chart).....III-121
1$200
   B. Market Analytics.....III-122
Table 146: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-122
1$200
   Table 147: Latin American Historic Review for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1231$200
   Table 148: Latin American 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Brazil, and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1241$200
   Table 149: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-1251$200
   Table 150: Latin American Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1261$200
   Table 151: Latin American 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1271$200
   Market Analysis.....III-128
Table 152: Brazilian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-128
1$200
   Table 153: Brazilian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1291$200
   Table 154: Brazilian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1301$200
   Market Analysis.....III-131
Table 155: Rest of Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-131
1$200
   Table 156: Rest of Latin America Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1321$200
   Table 157: Rest of Latin America 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1331$200
   A. Market Analysis.....III-134
Current and Future Analysis.....III-134
Omrix Biopharmaceuticals Ltd (Israel) - A Leading Plasma Fractionation
  Player.....III-134
1$75
   B. Market Analytics.....III-135
Table 158: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-135
1$200
   Table 159: Rest of World Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-1361$200
   Table 160: Rest of World 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-1371$200
  
Total Companies Profiled: 235 (including Divisions/Subsidiaries - 273)

Region/Country Players

The United States 128 Canada 10 Japan 12 Europe 53 France 4 Germany 16 The United Kingdom 12 Italy 4 Spain 3 Rest of Europe 14 Asia-Pacific (Excluding Japan) 63 Latin America 3 Africa 2 Middle East 2
Click here to request a full table of contents and more details on this project.